Breast cancer survival and prognosis by screening history
Background: Cancers not detected by breast screening are commonly assumed to have poorer prognosis. Methods: We examined the survival experience of all women aged 50–74 years diagnosed with a first breast cancer between 1998 and 2006 in British Columbia, Canada and determined their screening experie...
Saved in:
Published in: | British journal of cancer Vol. 110; no. 3; pp. 556 - 559 |
---|---|
Main Authors: | , |
Format: | Journal Article |
Language: | English |
Published: |
London
Nature Publishing Group UK
04-02-2014
Nature Publishing Group |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Background:
Cancers not detected by breast screening are commonly assumed to have poorer prognosis.
Methods:
We examined the survival experience of all women aged 50–74 years diagnosed with a first breast cancer between 1998 and 2006 in British Columbia, Canada and determined their screening experience. Disease-specific survival rates were calculated and, for cases diagnosed in 2002, prognostic factors (size, nodal involvement, grade ER status and stage) were examined by time since screening.
Results:
Breast cancers diagnosed at screening had the best survival (
P
<0.001). Cancers detected within 12 months of a negative screen had similar survival rates (
P
=0.98) to those diagnosed within 12–23 and 24–47 months, with other non-screen-detected cancers having poorer survival (
P
<0.001). The prognostic profile of cancers diagnosed in 2002 followed a similar pattern.
Interpretation:
There was no evidence that cancers diagnosed within 12 months had poorer prognosis than those diagnosed up to 48 months following screening. |
---|---|
AbstractList | Cancers not detected by breast screening are commonly assumed to have poorer prognosis.
We examined the survival experience of all women aged 50-74 years diagnosed with a first breast cancer between 1998 and 2006 in British Columbia, Canada and determined their screening experience. Disease-specific survival rates were calculated and, for cases diagnosed in 2002, prognostic factors (size, nodal involvement, grade ER status and stage) were examined by time since screening.
Breast cancers diagnosed at screening had the best survival (P<0.001). Cancers detected within 12 months of a negative screen had similar survival rates (P=0.98) to those diagnosed within 12-23 and 24-47 months, with other non-screen-detected cancers having poorer survival (P<0.001). The prognostic profile of cancers diagnosed in 2002 followed a similar pattern.
There was no evidence that cancers diagnosed within 12 months had poorer prognosis than those diagnosed up to 48 months following screening. Cancers not detected by breast screening are commonly assumed to have poorer prognosis. We examined the survival experience of all women aged 50-74 years diagnosed with a first breast cancer between 1998 and 2006 in British Columbia, Canada and determined their screening experience. Disease-specific survival rates were calculated and, for cases diagnosed in 2002, prognostic factors (size, nodal involvement, grade ER status and stage) were examined by time since screening. Breast cancers diagnosed at screening had the best survival (P<0.001). Cancers detected within 12 months of a negative screen had similar survival rates (P=0.98) to those diagnosed within 12-23 and 24-47 months, with other non-screen-detected cancers having poorer survival (P<0.001). The prognostic profile of cancers diagnosed in 2002 followed a similar pattern. There was no evidence that cancers diagnosed within 12 months had poorer prognosis than those diagnosed up to 48 months following screening. BACKGROUNDCancers not detected by breast screening are commonly assumed to have poorer prognosis. METHODSWe examined the survival experience of all women aged 50-74 years diagnosed with a first breast cancer between 1998 and 2006 in British Columbia, Canada and determined their screening experience. Disease-specific survival rates were calculated and, for cases diagnosed in 2002, prognostic factors (size, nodal involvement, grade ER status and stage) were examined by time since screening. RESULTSBreast cancers diagnosed at screening had the best survival (P<0.001). Cancers detected within 12 months of a negative screen had similar survival rates (P=0.98) to those diagnosed within 12-23 and 24-47 months, with other non-screen-detected cancers having poorer survival (P<0.001). The prognostic profile of cancers diagnosed in 2002 followed a similar pattern. INTERPRETATIONThere was no evidence that cancers diagnosed within 12 months had poorer prognosis than those diagnosed up to 48 months following screening. Background: Cancers not detected by breast screening are commonly assumed to have poorer prognosis. Methods: We examined the survival experience of all women aged 50–74 years diagnosed with a first breast cancer between 1998 and 2006 in British Columbia, Canada and determined their screening experience. Disease-specific survival rates were calculated and, for cases diagnosed in 2002, prognostic factors (size, nodal involvement, grade ER status and stage) were examined by time since screening. Results: Breast cancers diagnosed at screening had the best survival ( P <0.001). Cancers detected within 12 months of a negative screen had similar survival rates ( P =0.98) to those diagnosed within 12–23 and 24–47 months, with other non-screen-detected cancers having poorer survival ( P <0.001). The prognostic profile of cancers diagnosed in 2002 followed a similar pattern. Interpretation: There was no evidence that cancers diagnosed within 12 months had poorer prognosis than those diagnosed up to 48 months following screening. |
Author | Phillips, N Coldman, A J |
Author_xml | – sequence: 1 givenname: A J surname: Coldman fullname: Coldman, A J email: acoldman@bccancer.bc.ca organization: Cancer Surveillance and Outcomes, BC Cancer Agency – sequence: 2 givenname: N surname: Phillips fullname: Phillips, N organization: Cancer Surveillance and Outcomes, BC Cancer Agency |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28239110$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/24300976$$D View this record in MEDLINE/PubMed |
BookMark | eNptkUtrGzEURkVJaBy3u67LQAlkkXH1mLGkTaEJeYEhm3YtNJprR2YsubozBv_7yNh105CVJO7h0_045-QkxACEfGF0wqhQ35ulm3DKxEQK_oGMWC14yRSXJ2REKZUl1ZyekXPEZX5qquRHcsYrke9yOiL6OoHFvnA2OEgFDmnjN7YrbGiLdYqLENFj0WwLdAkg-LAonj32MW0_kdO57RA-H84x-X13--vmoZw93T_e_JyVrlK0L52sBROVZLahkkIrQALjtRLQVsLVjZCUc8ttBVJXVE7ruRUauG3ZlDpVOzEmP_a566FZQesg9Ml2Zp38yqatidab_yfBP5tF3BihWc2YyAGXh4AU_wyAvVl5dNB1NkAc0LBKa8ZqLlVGv71Bl3FIIdfbUZVQOi-Zqas95VJETDA_LsOo2Tkx2YnZOTHZSca_vi5whP9KyMDFAbDobDdP2YXHf5ziuUrOHZNyz2EehQWkV9u99_ELDBukHA |
CODEN | BJCAAI |
CitedBy_id | crossref_primary_10_1016_j_ypmed_2023_107723 crossref_primary_10_1634_theoncologist_2014_0036 crossref_primary_10_1097_MD_0000000000014617 crossref_primary_10_3390_ijms232113430 crossref_primary_10_1158_1055_9965_EPI_15_0804 crossref_primary_10_1007_s40258_017_0312_3 crossref_primary_10_1016_j_canep_2022_102312 crossref_primary_10_1111_1759_7714_12426 crossref_primary_10_1186_s42269_022_00823_y crossref_primary_10_1200_GO_23_00022 crossref_primary_10_1002_jum_14915 crossref_primary_10_1158_1055_9965_EPI_19_0416 crossref_primary_10_1177_08465371211027958 |
Cites_doi | 10.1136/bmj.e7536 10.1007/s10549-010-1318-9 10.1016/j.breast.2006.05.006 10.1007/BF01832353 10.1093/jnci/djq099 10.1136/jms.7.3.152 10.1038/sj.bjc.6602393 10.1258/jms.2009.009040 10.1016/S0140-6736(86)92569-9 |
ContentType | Journal Article |
Copyright | The Author(s) 2014 2015 INIST-CNRS Copyright Nature Publishing Group Feb 4, 2014 Copyright © 2014 Cancer Research UK 2014 Cancer Research UK |
Copyright_xml | – notice: The Author(s) 2014 – notice: 2015 INIST-CNRS – notice: Copyright Nature Publishing Group Feb 4, 2014 – notice: Copyright © 2014 Cancer Research UK 2014 Cancer Research UK |
DBID | C6C IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7RV 7TO 7U9 7X7 7XB 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AN0 AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB0 LK8 M0S M1P M7P NAPCQ PQEST PQQKQ PQUKI 7X8 5PM |
DOI | 10.1038/bjc.2013.732 |
DatabaseName | SpringerOpen Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Nursing & Allied Health Database Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central British Nursing Database ProQuest Central Essentials Biological Science Collection ProQuest Databases ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection (Proquest) (PQ_SDU_P3) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Biological Science Database Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest Central Student MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Breast cancer survival |
EISSN | 1532-1827 |
EndPage | 559 |
ExternalDocumentID | 3204655491 10_1038_bjc_2013_732 24300976 28239110 |
Genre | Journal Article |
GroupedDBID | --- -Q- 0R~ 23N 36B 39C 3V. 4.4 406 53G 5GY 5RE 6J9 70F 7RV 7X7 88E 8AO 8C1 8FI 8FJ 8R4 8R5 AANZL AAWBL AAWTL AAZLF ABAKF ABAWZ ABDBF ABLJU ABOCM ABUWG ABZZP ACAOD ACGFO ACGFS ACKTT ACPRK ACRQY ACZOJ ADBBV ADFRT ADHDB AEFQL AEJRE AEMSY AENEX AEVLU AFBBN AFKRA AFRAH AFSHS AGAYW AGEZK AGHAI AGQEE AHMBA AHSBF AILAN AJRNO ALFFA ALMA_UNASSIGNED_HOLDINGS AMYLF AN0 AOIJS ASPBG AVWKF AXYYD AZFZN B0M BAWUL BBNVY BENPR BHPHI BKEYQ BKKNO BNQBC BPHCQ BVXVI C6C CCPQU CS3 DIK DNIVK DPUIP DU5 E3Z EAD EAP EAS EBC EBD EBLON EBS EE. EIOEI EJD EMB EMK EMOBN EPL ESX EX3 F5P FDQFY FEDTE FERAY FIZPM FRJ FSGXE FYUFA GX1 HCIFZ HMCUK HVGLF HYE HZ~ IH2 IWAJR JSO JZLTJ KQ8 M1P M7P NAO NAPCQ NQJWS O9- OK1 P2P PQQKQ PROAC PSQYO Q2X RNT RNTTT RPM SNX SNYQT SOHCF SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TR2 TUS UKHRP W2D WH7 WOW ~02 ~8M .55 .GJ 08R 8WZ A6W AADWK AAPBV AAYJO ABDEU ABFLS ABGIJ ABPTK ACBMV ACBRV ACBYP ACDSR ACIGE ACTTH ACVWB ADGIM ADMDM ADQMX ADYYL AEDAW AEFTE AEXYK AGGBP AI. AJDOV AMRJV BBAFP CAG COF IQODW J5H M41 NYICJ PQEST PQUKI UDS VH1 X7M XFK Y6R ZA5 ZGI AAYZH CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TO 7U9 7XB 8FE 8FH 8FK AZQEC DWQXO GNUQQ H94 K9. LK8 7X8 5PM |
ID | FETCH-LOGICAL-c480t-c75313471ab070ed3e7e12583ed43c5b37022a2a4e7940765fa39e2ad160c85c3 |
IEDL.DBID | RPM |
ISSN | 0007-0920 |
IngestDate | Tue Sep 17 21:02:20 EDT 2024 Fri Oct 25 03:35:35 EDT 2024 Tue Nov 19 06:45:51 EST 2024 Thu Nov 21 22:30:50 EST 2024 Tue Oct 15 23:45:31 EDT 2024 Fri Nov 25 06:02:59 EST 2022 Fri Oct 11 20:37:40 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | breast screening survival interval cancer Breast disease Prognosis Breast cancer Malignant tumor Medical screening Survival Mammary gland diseases Cancerology Breast Mammary gland Cancer |
Language | English |
License | CC BY 4.0 From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c480t-c75313471ab070ed3e7e12583ed43c5b37022a2a4e7940765fa39e2ad160c85c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915113/ |
PMID | 24300976 |
PQID | 1494389794 |
PQPubID | 41855 |
PageCount | 4 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3915113 proquest_miscellaneous_1499115278 proquest_journals_1494389794 crossref_primary_10_1038_bjc_2013_732 pubmed_primary_24300976 pascalfrancis_primary_28239110 springer_journals_10_1038_bjc_2013_732 |
PublicationCentury | 2000 |
PublicationDate | 2014-02-04 |
PublicationDateYYYYMMDD | 2014-02-04 |
PublicationDate_xml | – month: 02 year: 2014 text: 2014-02-04 day: 04 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: Basingstoke – name: England |
PublicationTitle | British journal of cancer |
PublicationTitleAbbrev | Br J Cancer |
PublicationTitleAlternate | Br J Cancer |
PublicationYear | 2014 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Lawless (CR6) 1982 Chu, DeVita (CR2) 2001 Kalager, Tamimi, Bretthauer, Adami (CR5) 2012; 345 Frisell, von Rosen, Wiege, Nilsson, Goldman (CR3) 1992; 24 Holmberg, Adami, Tabar, Bergstrom (CR4) 1986; 2 Lawrence, O'Sullivan, Kearins, Tappenden, Martin, Wallis (CR7) 2009; 16 Wai, D'yachkova, Olivotto, Tyldesley, Phillips, Warren, Coldman (CR11) 2005; 92 Welch, Black (CR12) 2010; 102 Bordas, Jonsson, Nystrom, Lenner (CR1) 2006; 16 Miller (CR8) 2013 Olivotto, Kan, d'Yachkova, Burhenne, Hayes, Hislop, Worth, Basco, King (CR10) 2000; 7 Narod (CR9) 2011; 128 15714210 - Br J Cancer. 2005 Mar 14;92(5):961-6 20054093 - J Med Screen. 2009;16(4):186-92 20413742 - J Natl Cancer Inst. 2010 May 5;102(9):605-13 21203901 - Breast Cancer Res Treat. 2011 Jul;128(1):259-66 1463867 - Breast Cancer Res Treat. 1992;24(1):11-6 11126165 - J Med Screen. 2000;7(3):152-9 23160783 - BMJ. 2012;345:e7536 16875820 - Breast. 2007 Feb;16(1):47-54 2873324 - Lancet. 1986 Jul 5;2(8497):27-30 HG Welch (BFbjc2013732_CR12) 2010; 102 E Chu (BFbjc2013732_CR2) 2001 J Lawless (BFbjc2013732_CR6) 1982 G Lawrence (BFbjc2013732_CR7) 2009; 16 AB Miller (BFbjc2013732_CR8) 2013 ES Wai (BFbjc2013732_CR11) 2005; 92 M Kalager (BFbjc2013732_CR5) 2012; 345 IA Olivotto (BFbjc2013732_CR10) 2000; 7 P Bordas (BFbjc2013732_CR1) 2006; 16 J Frisell (BFbjc2013732_CR3) 1992; 24 L Holmberg (BFbjc2013732_CR4) 1986; 2 SA Narod (BFbjc2013732_CR9) 2011; 128 |
References_xml | – volume: 345 start-page: e7536 year: 2012 ident: CR5 article-title: Prognosis in women with interval breast cancer: population based observational cohort study publication-title: BMJ doi: 10.1136/bmj.e7536 contributor: fullname: Adami – volume: 128 start-page: 259 year: 2011 end-page: 266 ident: CR9 article-title: Age of diagnosis, tumor size, and survival after breast cancer: implications for mammographic screening publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-010-1318-9 contributor: fullname: Narod – volume: 16 start-page: 47 year: 2006 end-page: 54 ident: CR1 article-title: Survival from invasive breast cancer among interval cases in the mammography screening programmes of northern Sweden publication-title: Breast doi: 10.1016/j.breast.2006.05.006 contributor: fullname: Lenner – year: 1982 ident: CR6 publication-title: Statistical Models and Methods for Lifetime Data contributor: fullname: Lawless – start-page: 289 year: 2001 end-page: 292 ident: CR2 article-title: Principles of cancer management: chemotherapy publication-title: Cancer - Principles and Practice of Oncology contributor: fullname: DeVita – volume: 24 start-page: 11 year: 1992 end-page: 16 ident: CR3 article-title: Interval cancer and survival in a randomized breast cancer screening trial in Stockholm publication-title: Breast Cancer Res Treat doi: 10.1007/BF01832353 contributor: fullname: Goldman – start-page: 1267 year: 2013 ident: CR8 article-title: III.10 Screening publication-title: Handbook of Epidemiology contributor: fullname: Miller – volume: 102 start-page: 605 issue: 9 year: 2010 end-page: 613 ident: CR12 article-title: Overdiagnosis in Cancer publication-title: J Nat Cancer Inst doi: 10.1093/jnci/djq099 contributor: fullname: Black – volume: 7 start-page: 152 issue: 3 year: 2000 end-page: 159 ident: CR10 article-title: Ten years of breast screening in the Screening Mammography Program of British Columbia, 1988-1997 publication-title: J Med Screen doi: 10.1136/jms.7.3.152 contributor: fullname: King – volume: 92 start-page: 961 issue: 5 year: 2005 end-page: 966 ident: CR11 article-title: Comparison of 1- and 2-year screening intervals for women undergoing screening mammography publication-title: Br J Cancer doi: 10.1038/sj.bjc.6602393 contributor: fullname: Coldman – volume: 16 start-page: 186 issue: 4 year: 2009 end-page: 192 ident: CR7 article-title: Screening histories of invasive breast cancers diagnosed 1989-2006 in the West Midlands, UK: variation with time and impact on 10-year survival publication-title: J Med Screen doi: 10.1258/jms.2009.009040 contributor: fullname: Wallis – volume: 2 start-page: 27 year: 1986 end-page: 30 ident: CR4 article-title: Survival in breast cancer diagnosed between mammographic screening examinations publication-title: Lancet doi: 10.1016/S0140-6736(86)92569-9 contributor: fullname: Bergstrom – volume: 16 start-page: 47 year: 2006 ident: BFbjc2013732_CR1 publication-title: Breast doi: 10.1016/j.breast.2006.05.006 contributor: fullname: P Bordas – volume-title: Statistical Models and Methods for Lifetime Data year: 1982 ident: BFbjc2013732_CR6 contributor: fullname: J Lawless – volume: 2 start-page: 27 year: 1986 ident: BFbjc2013732_CR4 publication-title: Lancet doi: 10.1016/S0140-6736(86)92569-9 contributor: fullname: L Holmberg – volume: 128 start-page: 259 year: 2011 ident: BFbjc2013732_CR9 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-010-1318-9 contributor: fullname: SA Narod – volume: 7 start-page: 152 issue: 3 year: 2000 ident: BFbjc2013732_CR10 publication-title: J Med Screen doi: 10.1136/jms.7.3.152 contributor: fullname: IA Olivotto – volume: 16 start-page: 186 issue: 4 year: 2009 ident: BFbjc2013732_CR7 publication-title: J Med Screen doi: 10.1258/jms.2009.009040 contributor: fullname: G Lawrence – start-page: 289 volume-title: Cancer - Principles and Practice of Oncology year: 2001 ident: BFbjc2013732_CR2 contributor: fullname: E Chu – start-page: 1267 volume-title: Handbook of Epidemiology year: 2013 ident: BFbjc2013732_CR8 contributor: fullname: AB Miller – volume: 345 start-page: e7536 year: 2012 ident: BFbjc2013732_CR5 publication-title: BMJ doi: 10.1136/bmj.e7536 contributor: fullname: M Kalager – volume: 24 start-page: 11 year: 1992 ident: BFbjc2013732_CR3 publication-title: Breast Cancer Res Treat doi: 10.1007/BF01832353 contributor: fullname: J Frisell – volume: 102 start-page: 605 issue: 9 year: 2010 ident: BFbjc2013732_CR12 publication-title: J Nat Cancer Inst doi: 10.1093/jnci/djq099 contributor: fullname: HG Welch – volume: 92 start-page: 961 issue: 5 year: 2005 ident: BFbjc2013732_CR11 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6602393 contributor: fullname: ES Wai |
SSID | ssj0009087 |
Score | 2.231156 |
Snippet | Background:
Cancers not detected by breast screening are commonly assumed to have poorer prognosis.
Methods:
We examined the survival experience of all women... Cancers not detected by breast screening are commonly assumed to have poorer prognosis. We examined the survival experience of all women aged 50-74 years... Cancers not detected by breast screening are commonly assumed to have poorer prognosis. We examined the survival experience of all women aged 50-74 years... BACKGROUNDCancers not detected by breast screening are commonly assumed to have poorer prognosis. METHODSWe examined the survival experience of all women aged... |
SourceID | pubmedcentral proquest crossref pubmed pascalfrancis springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 556 |
SubjectTerms | 692/699/67/1347 692/699/67/2322 692/700/1750 Aged Biological and medical sciences Biomedical and Life Sciences Biomedicine Breast cancer Breast Neoplasms - diagnostic imaging Breast Neoplasms - pathology Breast Neoplasms - prevention & control Canada Cancer Research Drug Resistance Early Detection of Cancer Epidemiology Female Gynecology. Andrology. Obstetrics Humans Mammary gland diseases Mammography Mass Screening Medical sciences Middle Aged Molecular Medicine Multiple tumors. Solid tumors. Tumors in childhood (general aspects) Oncology Short Communication Survival Rate Tumors |
Title | Breast cancer survival and prognosis by screening history |
URI | https://link.springer.com/article/10.1038/bjc.2013.732 https://www.ncbi.nlm.nih.gov/pubmed/24300976 https://www.proquest.com/docview/1494389794 https://search.proquest.com/docview/1499115278 https://pubmed.ncbi.nlm.nih.gov/PMC3915113 |
Volume | 110 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9swED-tPExICMFgkAGVJwFvaRPbie3HjYF4aTVpIPEWObajFdG0atqH_vc756OjjKc952I7d-ezL3f3O4DLgqPFK1IeKk11yGWahMoyG1qao7l0KqfcVyPf_xLjJ_nj1sPkJF0tTJ20b_LJoHyZDsrJ7zq3cj41wy5PbPhzdONBzeOYDXvQw7th56J3SLuRbIAy_T84RaM22z1icpg_e9DCmA0E811sKGe-jCHdOpL25rpC7hRNW4v37p3_pk--iaHWR9PdAey3d0ryrVn7IXxw5Sf4OGqj5kegvvvM8yUxXsILUq3QPKCCEV1a4vOzylk1qUi-JmhC0K3FOUgDQ7w-hse724eb-7BtmRAaLqNlaND78MWhsc5xLzvLnHB4hZHMWc5MkjOBZzZKhTvch5FIk0Iz5ai2cRoZmRj2GXbKWelOgcjCOZqYVNG04FYYbYVCwjyWVnEtowCuOq5l8wYZI6sj2kxmyOjMMzpDRgfQ32LphhidPRRkjAOddzzO2g1UoUeifF92XGUAXzePUfV9PEOXbraqafD9hAoZwEkjkr-Dt7INQGwJa0PgYbW3n6C21fDarXYFcN2J9dWy3vnAL_89xRns4iC8TgLn57CzXKzcBfQqu-qjTo8f-rVm_wFee_sh |
link.rule.ids | 230,315,729,782,786,887,27933,27934,48284,48346,48347,48358,49590,49651,49652,49663,53800,53802 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9swDCa2BOgGDHt1D69ZpgJdb-5sSbakY7u2yLAkl6ZAcjJkS8a6g1PUyaH_fpQfSZPm0F0tSrZIkRJN8hPAUc7R4uUx95Wm2ucyjnxlmPENTdFcWpVS7qqRB1diPJXnFw4m56Sthamy3duQZGWp68Jw-SP96xAHQ3YiGJrcrsM5px3onk5ns_M1zG4ga5RM9wNO0aBJdd_uv7EJvbrVJfIjry-y2HXSfJwwuRU1rTajyzf_O4238Lo5dpLTep28g2e2eA97oyawvg_qzCWnL0jmFsEdKZdoQXANEl0Y4lK4inl5U5L0nqCVQc8XX0hqpOL7D3B9eTH5OfCbWxX8jMtg4WfooLj60VCnqO7WMCssnnIks4azLEqZwG0dBcctqmog4ijXTFmqTRgHmYwy9hE6xbywn4HI3FoaZbGicc6NyLQRCgnTUBrFtQw8-N6yObmtwTOSKujNZIJ8SBwfEuSDB_0NGayI0R9kaI1xoF4rlKTRsRKdFuWubsev9OBw1Yza4UIeurDzZUWD_SMqpAefahmuB-fMVbHEHogN6a4IHPL2Zktx86dC4Hao-mHIPDhuZfzgs3ZM8MtTCb_Bi8FkNEyGv8a_D-AlPuZVijjvQWdxt7Rf4Xlplv1m2f8DGDL_DA |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT8QgEJ74SIyJ8f2oT0zUW7UttIA3XxvN6mqiJt4aWmjUQ3djdw_-e4c-Vlc9mHgtA4UZGBhm5gNgL2Oo8bKIuVIFymUiCl2pqXZ1kKC6NDIJmM1GvrznnSdxfmFhco6bXJgy2r1xSVY5DRalKe8f9XRWJ4mLo-TVog_69JBTVL-T9kIMZ_fkabvduf2E3PVEhZhpL-Nk4NVh79_rj2xIMz1VIG-y6lGL306dP4Mnv3lQy42pNfefIc3DbH0cJSfV_FmAMZMvwtRN7XBfAnlqg9b7JLWT440UA9QsODeJyjWxoV15t3gpSPJOUPugRYw_JxWC8fsyPLYuHs4u3fq1BTdlwuu7KRouNq_UVwmqAaOp4QZPP4IazWgaJpTjdo8CZQaXsMejMFNUmkBpP_JSEaZ0BSbybm7WgIjMmCBMIxlEGdM8VZpLJEx8oSVTwnNgv2F53KtANeLSGU5FjHyILR9i5IMD2yPyGBKjnUhRS2NDm42A4nrtFWjMSPukO_bSgd1hMa4a6wpRuekOShqsHwZcOLBayfOzcUZtdkvkAB-R9JDAInKPluQvzyUyt0Xb933qwEEj7y_d-mWA638l3IGpu_NWfH3VaW_ANH5lZeQ424SJ_tvAbMF4oQfb9Qr4AMX6B8g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Breast+cancer+survival+and+prognosis+by+screening+history&rft.jtitle=British+journal+of+cancer&rft.au=Coldman%2C+A+J&rft.au=Phillips%2C+N&rft.date=2014-02-04&rft.pub=Nature+Publishing+Group+UK&rft.issn=0007-0920&rft.eissn=1532-1827&rft.volume=110&rft.issue=3&rft.spage=556&rft.epage=559&rft_id=info:doi/10.1038%2Fbjc.2013.732&rft.externalDocID=10_1038_bjc_2013_732 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-0920&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-0920&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-0920&client=summon |